Research and Markets: Global Schizophrenia (First and Second Generation) Therapeutics Market 2014-2018: Increase in Generic Competition

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/f4jkpw/global) has announced the addition of the "Global Schizophrenia Therapeutics Market 2014-2018" report to their offering.

The Global Schizophrenia Therapeutics market to grow at a CAGR of 2.82% over the period 2013-2018

One major trend in this market is the increase in the awareness of schizophrenia. The awareness among patients and physicians is expected to increase the penetration of drugs in the market.

According to the report, an increase in the aging population worldwide is one of the main drivers of the market. Aging is one of the main causes of CNS disorders, including schizophrenia. Therefore, the global burden of the disorder is increasing because of the rapidly aging population in different parts of the world.

Further, the report states that an increase in the generic competition is one of the main challenges that the market confronts. The availability of low-cost generic drugs intensifies the competition among the vendors and thus substantially reduces the cost of patented/branded drugs.

The Global Schizophrenia Therapeutics market can be segmented into two:

  • First-generation Antipsychotics
  • Second-generation Antipsychotics

Key Vendors

  • AstraZeneca
  • Bristol-Myers Squibb
  • Eli Lily
  • F. Hoffmann-La Roche
  • H. Lundbeck
  • Johnson & Johnson
  • Otsuka Pharmaceuticals
  • Pfizer
  • Sumitomo Dainippon Pharma¬†

Key Topics Covered:

  1. Executive Summary
  2. List of Abbreviations
  3. Scope of the Report
  4. Market Research Methodology
  5. Introduction
  6. Market Landscape
  7. Pipeline Snapshot
  8. Rate of Incidence and Prevalence
  9. Types of Schizophrenia
  10. Phases of Schizophrenia
  11. Market Segmentation by Drug Class
  12. Geographical Segmentation
  13. Buying Criteria
  14. Market Growth Drivers
  15. Drivers and their Impact
  16. Market Challenges
  17. Impact of Drivers and Challenges
  18. Market Trends
  19. Trends and their Impact
  20. Vendor Landscape
  21. Key Vendor Analysis

For more information visit http://www.researchandmarkets.com/research/f4jkpw/global.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals